Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) EBIT Margin: 2013-2024

Historic EBIT Margin for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to 11.2%.

  • Surgery Partners' EBIT Margin rose 49600.0% to 12.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.36%, marking a year-over-year increase of 15400.0%. This contributed to the annual value of 11.2% for FY2024, which is 7600.0% down from last year.
  • Latest data reveals that Surgery Partners reported EBIT Margin of 11.2% as of FY2024, which was down 7600.0% from 11.96% recorded in FY2023.
  • In the past 5 years, Surgery Partners' EBIT Margin registered a high of 13.59% during FY2022, and its lowest value of 9.84% during FY2020.
  • Over the past 5 years, Surgery Partners' median EBIT Margin value was 11.96% (recorded in 2023), while the average stood at 12.03%.
  • In the last 5 years, Surgery Partners' EBIT Margin tumbled by -30400bps in 2020 and then skyrocketed by 37400bps in 2021.
  • Over the past 5 years, Surgery Partners' EBIT Margin (Annual) stood at 9.84% in 2020, then surged by 38bps to 13.58% in 2021, then grew by 0bps to 13.59% in 2022, then decreased by -12bps to 11.96% in 2023, then dropped by -6bps to 11.2% in 2024.
  • Its EBIT Margin was 11.2% in FY2024, compared to 11.96% in FY2023 and 13.59% in FY2022.